γδ-T Cell Cryopreservation Solution (10% DMSO), 100 mL, Cellstore (CAT#: STEM-CT-2297-ZJF)

Cellstore's γδ-T Cell Cryopreservation Solution overcomes the limitations of traditional cryopreservation media, significantly enhancing the viability and functionality of γδ-T cells post-thaw. Within 24 hours of thawing, the viability of γδ-T cells increases by 51% compared to competing brands, and the tumor-killing rate reaches 84.3%, nearly doubling the efficacy of fresh cells. This solution enables a sufficient quantity of viable γδ-T cells for therapeutic applications, reducing R&D and production costs, and laying the foundation for advancing cell therapies towards off-the-shelf availability.

Volume: 100ml
Technology: Developed using controlled-rate freezing technology, incorporating dual cryoprotectants with proprietary ice-controlling agents and 10% USP-grade DMSO.
Cell Viability: Greater than 90%
Composition: Serum-free, protein-free, and devoid of animal-derived components, formulated with pharmacopeial-grade materials.
Sterility: Sterile, with endotoxin levels below 0.125 EU/mL
Safety and Usability: High safety, superior recovery rates, and exceptional ease of use.
Storage and Transport: Ready-to-use, stable for storage and long-distance transport at 2-8°C.
High-Density Cryopreservation: Supports ultra-high-density cryopreservation from 1×10 to 1×10^8 cells/mL.
Direct Freezing Capability: Facilitates direct freezing without the need for programmed cooling, suitable for short-term storage at -80°C or long-term preservation in liquid hydrogen after 12 hours.

Breakthrough Technology: Marks a pioneering advancement in the cryopreservation of γδ-T cells, addressing a significant challenge in cell therapy.
Enhanced Viability and Functionality: Ensures a significant increase in cell viability and tumor-killing capacity post-thaw, surpassing existing solutions.
Reduced R&D and Production Costs: Offers a cost-effective solution for developing and manufacturing cell therapies, enhancing efficiency and productivity.
Foundation for Off-the-Shelf Cell Therapies: Contributes to the development of readily available cell-based medicinal products, revolutionizing the field of cell therapy.

PBMC Cryopreservation Solution (DMSO-Free), 100 mL, Cellstore
αβ-T Cell Cryopreservation Solution (DMSO-Free), 100 mL, Cellstore
NK Cell Cryopreservation Solution (10% DMSO), 100 mL, Cellstore
Pius Cell Cryopreservation Solution (10% DMSO), 100 mL, Cellstore